RENO, Nev. (PRWEB) May 19, 2020
Today Dr. Kent Sasse announced the issuance of a non-provisional patent for his new sleeve tube device, a major breakthrough in the field of metabolic surgery. Millions with type 2 diabetes will benefit from Dr. Sasse’s revolutionary device – the best cure for diabetes.
The new device, Non-Provisional Patent Serial No. 15/838,057, H & H Reference No. (88537.0006), is designed to improve the sleeve gastrectomy procedure, a metabolic surgery that reduces the risk of life-threatening weight-related health conditions, including type 2 diabetes.
Unlike previous devices, the sleeve tube takes its shape from the natural contours of the body and curvature of the stomach, enabling the surgeon to perform each procedure in a manner that conforms to the human body and produces a more natural result.
“The sleeve tube is the culmination of years of work to make sleeve gastrectomy safer, simpler and more effective,” says inventor Dr. Sasse. Dr. Sasse is the medical director of a nationally accredited center for metabolic and bariatric surgery that has produced a breakthrough in reducing the leak rate to 0.0% in over 2,500 consecutive sleeve gastrectomy procedures.
“Through years of study of sleeve gastrectomy, we determined where the increased pressure zones arise, and how to lower complications of leak and stenosis with this new device,” says Dr. Sasse. With continuing innovations like the Sleeve Tube, Dr. Sasse says, “Metabolic surgery today is a 45-minute procedure with four Band-aids that is safer than an appendectomy. More importantly, it is the safest and most effective treatment of type 2 diabetes today.”
Also known as laparoscopic sleeve gastrectomy (LSG), sleeve gastrectomy is one of the most performed and successful minimally invasive surgical procedures available today. In addition to being the safest and most effective treatment for type 2 diabetes and obesity, sleeve gastrectomy reduces the risk of heart disease, stroke, infertility, degenerative joints and obstructive sleep apnea.
Learn more about sleeve gastrectomy.
About Dr. Sasse
Kent C. Sasse MD, MPH, FACS, FASCRS, FASMBS, is an honors graduate of the University of California, San Francisco, and holds multiple board certifications including with the American Society for Metabolic and Bariatric Surgery. Dr. Sasse has received numerous honors over the course of his distinguished career and has a deep-rooted passion for teaching, innovation and metabolic health. He is a member of the faculty of the University of Nevada School of Medicine and the author of The Type II Diabetes Cure, a 2019 book on metabolic surgery and diabetes. Learn more about Dr. Sasse at http://www.sassesurgical.com.
For Media Inquiries, please contact Dr. Sasse: